Sjögren's syndrome associated with chronic hepatitis C, severe thrombocytopenia, hypertrophic cardiomyopathy, and diabetes mellitus

Internal Medicine

Volumn 44, Issue 6, 2005, Pages 657-661

  Kamimura, Takeshi ^d   Sato, Hidetomo ^a   Iwamoto, Masahiro ^d   Nara, Hiroyuki ^d   Torikoe, Kimiaki ^b   Masuyama, Jun Ichi ^c   Okazaki, Hitoaki ^d   Minota, Seiji ^d  

^a NASU RED CROSS HOSPITAL   (Japan)

^b Biwako Ohashi Hospital   (Japan)

^c 1 1F TOC Ohsaki Building   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Extrahepatic manifestation; Hepatitis C virus (HCV); Sj gren's sydrome; Sudden death; Thrombocytopenia

Indexed keywords

DANAZOL; DEXAMETHASONE; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN; INSULIN; METHYLPREDNISOLONE; PREDNISONE; URSODEOXYCHOLIC ACID;

AGED; ANAMNESIS; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CLINICAL FEATURE; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART PALPITATION; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERGAMMAGLOBULINEMIA; HYPERTROPHIC CARDIOMYOPATHY; LABORATORY TEST; LIVER DYSFUNCTION; PATIENT REFERRAL; RECURRENT DISEASE; SJOEGREN SYNDROME; THROMBOCYTOPENIA; UTERUS MYOMA;

BIOPSY; BONE MARROW; CARDIOMYOPATHY, HYPERTROPHIC; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; MIDDLE AGED; SALIVARY GLANDS; SJOGREN'S SYNDROME; THROMBOCYTOPENIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 21644460985     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.657     Document Type: Article

References (23)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 345: 41-52, 2001.
2. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 24: 135-140, 1996.
3. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 222: 678-682, 1996.
4. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339: 321-323, 1992.
5. Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 4: 9-28, 1997.
6. Toussirot E, Le Huede G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection. J Rheumatol 29: 2382-2385, 2002.
7. Aoki A, Ohno S, Ueda A, et al. Hematological abnormalities of primary Sjögren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 23: 124-128, 2000 (in Japanese, Abstract in English).
8. Gyongyosi M, Pokorny G, Jambrik Z, et al. Cardiac manifestations in primary Sjögren's syndrome. Ann Rheum Dis 55: 450-454, 1996.
9. Ramos-Casals M, Garcia-Carrasco M, Cervera R, et al. Hepatitis C virus infection mimicking primary Sjögren's syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 80: 1-8, 2001.
10. Matsumori A, Ohashi N, Sasayama S. Hepatitis C virus infection and hypertrophic cardiomyopathy. Ann Intern Med 129: 749-750, 1998.
11. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29: 328-333, 1999.
12. Koike K, Moriya K, Ishibashi K, et al. Sialadenitis histologically resembling Sjögren's syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 94: 233-236, 1997.
13. Loustaud-Ratti V, Riche A, Liozon E, et al. Prevalence and characteristics of Sjögren's syndrome or sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol 28: 2245-2251, 2001.
14. Sugai S, Tachibana J, Shimizu S, Konda S. Thrombocytopenia in patients with Sjögren's syndrome. Arthritis Rheum 32: 234-235, 1989.
15. Sakuraya M, Murakami H, Uchiumi H, et al. Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection. Eur J Haematol 68: 49-53, 2002.
16. Rajan S, Liebman HA. Treatment of hepatitis C related thrombocytopenia with interferon alpha. Am J Hematol 68: 202-209, 2001.
17. Hernandez F, Blanquer A, Linares M, Lopez A, Tarin F, Cervero A. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 99: 217-220, 1998.
18. Shrestha R, McKinley C, Bilir BM, Everson GT. Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection. Am J Gastroenterol 90: 1146-1147, 1995.
19. Matsumori A, Ohashi N, Hasegawa K, et al. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Jpn Circ J 62: 389-391, 1998.
20. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 336: 775-785, 1997.
21. Matsumori A. Hepatitis C virus and cardiomyopathy. Herz 25: 249-254, 2000.
22. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126: 840-848, 2004.
23. Maeno T, Okumura A, Ishikawa T, et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 18: 1358-1363, 2003.